Docebo (NASDAQ:DCBO - Get Free Report) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating in a note issued to investors on Monday,Briefing.com Automated Import reports. They currently have a $32.00 price objective on the stock. Morgan Stanley's price target indicates a potential upside of 20.66% from the company's previous close.
Several other analysts have also recently commented on the stock. National Bank Financial cut shares of Docebo from an "outperform" rating to a "sector perform" rating in a research note on Friday. Scotiabank reduced their price objective on shares of Docebo from $55.00 to $45.00 and set a "sector outperform" rating for the company in a research report on Tuesday, March 4th. National Bankshares dropped their target price on Docebo from $55.00 to $45.00 and set an "outperform" rating on the stock in a research report on Friday, April 25th. UBS Group set a $45.00 price target on Docebo in a report on Tuesday, March 4th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $42.00 price objective on shares of Docebo in a report on Thursday, April 10th. Three analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Docebo has a consensus rating of "Moderate Buy" and an average price target of $49.64.
Get Our Latest Analysis on Docebo
Docebo Trading Down 17.2%
DCBO opened at $26.52 on Monday. Docebo has a 12 month low of $26.00 and a 12 month high of $53.86. The stock has a market capitalization of $787.35 million, a price-to-earnings ratio of 45.72 and a beta of 1.57. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.13 and a quick ratio of 1.13. The business has a fifty day moving average price of $30.06 and a 200 day moving average price of $39.74.
Institutional Trading of Docebo
Institutional investors and hedge funds have recently made changes to their positions in the stock. Quantbot Technologies LP bought a new stake in shares of Docebo during the 4th quarter worth $132,000. Tower Research Capital LLC TRC lifted its position in Docebo by 46.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,983 shares of the company's stock worth $134,000 after acquiring an additional 949 shares during the last quarter. Barclays PLC acquired a new position in Docebo during the 3rd quarter worth $142,000. Deutsche Bank AG bought a new stake in Docebo during the fourth quarter valued at about $242,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Docebo in the fourth quarter valued at about $255,000. Institutional investors and hedge funds own 53.17% of the company's stock.
Docebo Company Profile
(
Get Free Report)
Docebo Inc operates as a learning management software company that provides artificial intelligence (AI)-powered learning platform in North America and internationally. It offers Learning Management System (LMS) to train internal and external workforces, partners, and customers. The company's cloud platform consists of a learning suite, which includes Docebo Learn LMS, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Shape, an AI-based learning content creation tool, which enables learning administrators to turn internal and external resources into engaging, multilingual, and microlearning content to share across the business; Docebo Content that allows off-the-shelf learning content by partnering content specialist; Docebo Learning Impact, a learning measurement tool that enables administrators to prove and improve training programs; Docebo Learn Data, which gives a comprehensive view on learning data to business results; Docebo Connect that connects Docebo to custom tech stack and making integrations; and Docebo Flow that allows businesses to directly inject learning into the flow of work.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docebo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docebo wasn't on the list.
While Docebo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.